Expertise in
1
conditions

Claudio Dazzi

Ravenna, IT 
Expertise in
1
conditions
Ravenna, IT 

Overview

Claudio Dazzi practices practicing medicine in Ravenna, Italy.

Mr. Dazzi is highly rated in 1 condition, according to our data. His clinical expertise encompasses Lung Cancer, Small Cell Lung Cancer (SCLC), Glioblastoma, and Astrocytoma.

He is actively involved in clinical research, co-authoring 22 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

Ravenna, Italy
Other Locations
Bologna, Italy
Meldola, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Phase 3 Randomized Study Comparing X-396 (Ensartinib) to Crizotinib in Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) Patients
Phase 3 Randomized Study Comparing X-396 (Ensartinib) to Crizotinib in Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) Patients
Enrollment Status: Active_not_recruiting
Publish Date: October 14, 2025
Intervention Type: Drug
Study Drugs: X-396 (Ensartinib), Crizotinib
Study Phase: Phase 3
NGR019: Randomized Double-blind Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced Malignant Pleural Mesothelioma (MPM)
NGR019: Randomized Double-blind Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced Malignant Pleural Mesothelioma (MPM)
Enrollment Status: Completed
Publish Date: January 15, 2019
Intervention Type: Drug, Other
Study Phase: Phase 2
Phase II Trial of Temozolomide in Patients Affected by Relapsed Sensitive or Refractory Small Cell Lung Cancer With MGMT Methylation (TeRes). GOPAV03
Phase II Trial of Temozolomide in Patients Affected by Relapsed Sensitive or Refractory Small Cell Lung Cancer With MGMT Methylation (TeRes). GOPAV03
Enrollment Status: Terminated
Publish Date: November 13, 2018
Intervention Type: Drug
Study Phase: Phase 2
Randomized Cross-over Study of Patient Preference for Oral or Intravenous Vinorelbine in the Treatment of Advanced NSCLC. A Phase IV Study.
Randomized Cross-over Study of Patient Preference for Oral or Intravenous Vinorelbine in the Treatment of Advanced NSCLC. A Phase IV Study.
Enrollment Status: Completed
Publish Date: November 09, 2018
Intervention Type: Drug
Study Phase: Phase 4
Open-label, Multicenter, Randomized Phase II Trial of Treatment With Cisplatin and Pemetrexed or Cisplatin and Oral Vinorelbine in Chemotherapy Naïve Patients Affected by Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer With High Thymidylate Synthase Expression
Open-label, Multicenter, Randomized Phase II Trial of Treatment With Cisplatin and Pemetrexed or Cisplatin and Oral Vinorelbine in Chemotherapy Naïve Patients Affected by Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer With High Thymidylate Synthase Expression
Enrollment Status: Terminated
Publish Date: January 16, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

21 Total Publications

Nintedanib as switch maintenance treatment in malignant pleural mesothelioma (NEMO): A double-blind randomized phase II trial (EORTC-08112-LCG).
Nintedanib as switch maintenance treatment in malignant pleural mesothelioma (NEMO): A double-blind randomized phase II trial (EORTC-08112-LCG).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 27, 2025

Frequently Asked Questions about Claudio Dazzi

Is Claudio Dazzi a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Claudio Dazzi is classified as an Advanced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Claudio Dazzi participate in research or clinical trials?

Yes. Claudio Dazzi has published 21 articles and abstracts on conditions like Lung Cancer. You can view a list of Claudio Dazzi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Dazzi's expertise for a condition
ConditionClose
      View All 9 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile